Michael Green

• J.D., University of Pennsylvania, 1975
• B.S., Tufts University, 1972

• Insurance
• Mass Torts
• Medical Malpractice
• Products Liability
• Toxic Torts

Books

• Tort Law and Alternatives: Cases and Materials (2016) (with Marc Franklin, Robert Rabin, Mark Geistfeld).
• Educational Module on Scientific Evidence of Factual Causation (National Academy of Sciences 2016).
• Proportional Liability: Analytical and Comparative Perspectives (De Gruyter 2013).
• Products Liability: Cases and Materials (5th ed.) (West 2013).
• Restatement (Third) of Torts: Liability for Physical and Emotional Harm (American Law Institute 2012).
• Tort Law and Alternatives: Cases and Materials (2011).
• Toxic and Environmental Torts (2011).
• Restatement (Third) of Torts: Liability for Physical and Emotional Harm Volume I (West 2009).
• Gilbert Law Summaries: Torts (2008) (with Jonathan Cardi, Marc Franklin).
• Tort Law and Alternatives: Cases and Materials (2006) (with Marc Franklin, Robert Rabin).
• Products Liability: Cases and Materials (2006) (with David Fischer, Wiliam Powers, Jr., Joe Sanders).
• Products Liability: Cases and Materials (2002) (with David Fischer, Wiliam Powers, Jr., Joe Sanders).
• Restatement (Third) of Torts: Apportionment of Liability (2000).
• Bendectin and Birth Defects: The Challenges of Mass Toxic Substances (U. Pa. Press 1996).
• Products Liability Problems (1995) (with P. LeBel, D. Owen).
• Case and Statutory Supplement to Products Liability and Safety (1993) (with P. Keeton, D. Owen, J. Montgomery).
• Teachers’ Manual for Products Liability and Safety (1990) (with P. Keeton, D. Owen, J. Montgomery).
• Products Liability and Safety (1989) (with P. Keeton, D. Owen, J. Montgomery).

Book Chapters

• The Borderlines of Tort Law in the United States, in The Borderlines of Tort Law: Interactions with Contract Law (European Group on Tort Law) (2019).
• Professor Francis Herman Bohlen (1868-1942), in Scholars of Tort Law (2019).
• Frances H. Bohlen, in PRIVATE LAW SCHOLARS.
• Products Liability in North America, in Product Liability: Fundamental Questions of Product Liability in a Comparative Perspective (2017).
• The Liability of Public Authorities in the United States, in The Liability of Public Authorities in Comparative Perspective (Ken Oliphant, ed. 2016).
• Product Liability in the United States of America, in European Product Liability: An Analysis of the State of the Art in the Era of New Technologies (Piotr Machnikowski, ed. 2016).
• Admissibility versus Sufficiency: Controlling the Quality of Expert Witness Testimony in the United States, in Uncertain Causation in Tort Law (Miquel Martin-Casals and Diego M. Papayanis, eds. 2016).
• Basic Questions of Tort Law from the Perspective of the USA, in Basic Questions of Tort Law from a Comparative Perspective (Helmut Koziol, ed. 2015).
• Considerations of Risk-Spreading and Compensation of Damage, in Comparative Stimulations for Developing Tort Law (Helmut Koziol, ed. 2015).
• Delict and Proportional Liability, in Essays in Honor of Johann Neethling (Johan Potgeiter, Johann Knobel & Rita-Marie Jansen, eds. 2015).
• Epidemiologic Evidence in Toxic Tort Cases, in Forensic Epidemiology (2016).
• Tort Law to the Rescue, in Functional or Dysfunctional – the Law as a Cure 187-203 (Lars Gorton, Jan Kleineman, and Hans Wiboom 2014).
• United States Response to Basic Questions on Tort Law from a Germanic Perspective, in Basic Questions on Tort Law from a Germanic Perspective (2014).
• Causal Uncertainty and Proportional Liability in the U.S., in Proportional Liability: Analytical and Comparative Perspectives 343 (2013).
• Causal Uncertainty and Proportional Liability: Analytical and Comparative Report, in Proportional Liability: Analytical and Comparative Perspectives (2013).
• Toxic Torts, in Encyclopedia of Toxicology (2014).
• Employers’ Liability and Workers’ Compensation in the United States, in Employers’ Liability (Ken Oliphant, ed. 2012).
• Reference Guide on Epidemiology, in Reference Manual on Scientific Evidence 2011 (2011).
• Aggregation and Divisibility of Damage in the United States: Tort Law and Insurance, in Aggregation and Divisibility of Damage 379-424 (Ken Oliphant 2009).
• The Impact of the Jury on American Tort Law, in European Tort Law 2005 (Helmut Koziol & Barbara C. Steininger eds. 2006).
• The Future of Proportional Liability, in Exploring Tort Law (Stuart Madden ed. 2005).
• Multiple Tortfeasors Under U.S. Law, in Unification of Tort Law: Multiple Tortfeasors 259 (W.V. Horton Rogers ed. 2004 2004).
• Reference Guide on Epidemiology, in Reference Manual on Scientific Evidence (2000).
• Reference Guide on Epidemiology, in Reference Manual on Scientific Evidence (1994).
• Tort Law, Deterrence and Innovation: Too Much or Too Little?, in in National Academy of Sciences–Building Research Board, The Role of Public Agencies in Fostering New Technology and Innovation in Building (A. Lemer & D. Dibner eds. 1992).
• The Private Law Implications of Regulatory Risk Communication in the United States, in Corporate Disclosure of Environmental Risks (M. Baram & D. Partan eds. 1990).

Articles

• Pharmaceutical product liability in the United States of America, 20 Pharmaceuticals Policy and Law 23 (2018).
• Pharmaceutical product liability in the United States of America, 20 Pharmaceuticals Policy and Law 23-39 (2018).
• Cardozo and the Civil Jury, 34 Touro Law Review 183 (2018).
• Do Courts Engage in a Sufficiency Analysis When Making Daubert Rulings in Tort Cases?, University of Connecticut Law Review forthcoming.
• Positive Externalities and the Economics of Proximate Cause, 74 Washington & Lee Law Review 1517 (2017).
• Maligned Misalignments, 74 Washington and Lee Law Review 1517 (2017).
• Asbestos Victims Fight Asbestos Reform Legislation, Top Class Actions (2016).
• Admissibility Versus Sufficiency: Controlling the Quality of Expert Witness Testimony, 50 Wake Forest Law Review 1057 (2016).
• In Defense of Sufficiency: A Reply to Professor Twerski and Mr. Sapir, 23 Widener Law Journal 663-680 (2014).
• Drafting a Torts Restatement: Of Swiss Cheese, Gravity, and Process, 22 Tort Law Review 31-56 (2014).
• Pessimism about Milward, 3 Wake Forest Journal of Law and Public Policy 41 (2013).
• 比例責任 (On Proportional Liability), 1 Anglo-American Law Review 155 (2013).
• Who Is Now Responsible for Discovering and Warning About Adverse Effects of Generic Drugs?, 310 Jounal of the American Medical Association 1023 (2013).
• The Liability of Public Authorities in the United States, Principles of European Tort Law (2013).
• Restating Tort Law: The American and European Styles, 3 Journal of European Tort Law 281 (2012).
• The Federal Employers’ Liability Act: Sense and Nonsense about Causation, 61 DePaul Law Review 503 (2012).
• Darvon’s turn in the limelight; First pharma MDL in years could revolve around the pain drug, The National Law Journal (2011).
• The Impact of the Civil Jury on American Tort Law, 38 Pepperdine Law Review 337-57 (2011).
• Introduction: The Third Restatement of Torts in a Crystal Ball, 37 William Mitchell Law Review 993 (2011).
• Conceptual Clarity and Necessary Muddles, 90 Texas Law Review 41 (2011).
• The New Restatement’s Top Ten Tools, Trial (2010).
• The Unappreciated Congruity of the Second and Third Restatements on Design Defects, 74 Brooklyn Law Review 807-37 (2009).
• Second Thoughts on Asbestos Apportionment, 37 Southwestern University Law Review 531 (2009).
• The Insubstantiality of the “Substantial Factor” Test for Causation, 73 Missouri Law Review 399 (2008).
• Duty Wars, 81 Southern California Law Review 671 (2008).
• The Intersection of Factual Causation and Damages, 55 DePaul Law Review 671 (2006).
• Apportionment, Victim Reliance, and Fraud: A Commentary, 48 Arizona Law Review 1027 (2006).
• A Future for Asbestos Apportionment?, 12 Connecticut Insurance Law Journal 315 (2006).
• The Unanticipated Ripples of Comparative Negligence: Superseding Cause in Products Liability and Beyond, 53 South Carolina Law Review 1103 (2002).
• The Magic of Gary’s Scholarship, 50 UCLA Law Review 337 (2002).
• Symposium Introduction: Empirical Approaches to Establishing the Medical Standard of Care, 37 Wake Forest Law Review 663 (2002).
• Physician Surveys to Assess Customary Care in Medical Malpractice Cases, 17 Journal of General Internal Medicine 546 (2002).
• Ascertaining Customary Care in Malpractice Cases: Asking Those Who Know, 37 Wake Forest Law Review 699 (2002).
• Tort Law Deference to FDA Regulation of Medical Devices, 88 Georgetown Law Journal 2119 (2000).
• Apportionment of Liability, 10 Kansas Journal of Law and Public Policy 30 (2000).
• A. Leo Levin: A Fond Tribute to the Master of the Classroom, 148 University of Pennsylvania Law Review 1357 (2000).
• Prescription Drugs, Alternative Designs, and the Restatement (Third): Preliminary Reflections, 30 Seton Hall Law Review 207 (1999).
• The Road Less Well Traveled (And Seen): Contemporary Law Making in Products Liability, 49 DePaul Law Review 377 (1999).
• The Impact of Daubert on Statistically-Based Evidence in the Courts, 1998 Proceedings of the Section on Statistics of Epidemiology 35 (1998).
• Fairness and Successor Liability: The Limits of the Common Law Process, 8 Kansas Journal of Law and Public Policy 119 (1998).
• Safety as an Element of Pharmaceutical Quality: The Respective Roles of Regulation and Tort Law, 42 Saint Louis University Law Journal 163 (1998).
• Cipollone Revisited: A Not So Little Secret About the Scope of Cigarette Preemption, 82 Iowa Law Review 1257 (1998).
• Statutory Compliance and Tort Liability: Examining the Strongest Case, 20 University of Michigan Journal of Law Reform 461 (1997).
• Science is to Law as the Burden of Proof is to Significance Testing (book review), 37 Jurimetrics 205 (1997).
• Negligence = Economic Efficiency: Doubts >, 75 Texas Law Review 1605 (1997).
• Legacies of the Bendectin Case (book review), 278 Science 1574 (1997).
• When Science Clashes With Law (book review), Chemical & Engineering News 63 (1996).
• The Schizophrenia of Risk-Benefit Analysis in Design Defect Litigation, 48 Vanderbilt Law Review 609 (1995).
• Successors and CERCLA: The Imperfect Analogy to Products Liability and an Alternative Proposal, 87 Northwestern Law Review 897 (1993).
• Relief at the Frying of Frye: Reflections on Daubert v. Merrell Dow Pharmaceuticals, 1 Shepard’s Expert & Scientific Evidence Quarterly 43 (1993).
• Expert Witnesses and Sufficiency of Evidence in Toxic Substances Litigation: The Legacy of Agent Orange and Bendectin Litigation, 86 Northwestern University Law Review 643 (1992).
• The Supreme Court and the Products Liability Crisis: Lessons from Boyle’s Government Contractor Defense, 63 Southern California Law Review 637 (1990).
• When Toxic Worlds Collide: Prescriptions for Regulatory and Common Law Reform for Risk Communication, 13 Harvard Environmental Law Review 209 (1989).
• The Paradox of Statutes of Limitations in Insidious Disease Litigation, 76 California Law Review 965 (1989).
• Contingent Attorneys’ Fees: Theory and Experience, 62 Law Institute Journal 1182 (1988).
• Successor Liability: The Superiority of Statutory Reform to Protect Products Liability Claimants, 72 Cornell Law Review 17 (1986).
• The Inability of Offensive Collateral Estoppel to Fulfill Its Promise: An Examination of Estoppel in Asbestos Litigation, 70 Iowa Law Review 141 (1984).
• From Here to Attorney’s Fees: Certainty, Efficiency and Fairness in the Journey to the Appellate Courts, 69 Cornell Law Review 207 (1984).

Other

• All You Ever Wanted to Know About Adequate Proof of Causation in Tort Law, Journal of European Tort Law (2018).
• Facebook defamation leads to $500K settlement (February 12, 2017).
• After $50 million settlement, victims’ mother blasts Ikea for leaving ‘silent killer’ on the market (December 23, 2016).
• Ikea balks at releasing records tied to deadly dresser recall (August 30, 2016).
• Let’s Be Careful Out There, TortsProf Blog (January 25, 2010).
• Gilbert Law Summaries, Torts, 25th ed. (2008).
• Brief of Senator Edward Kennedy and Representative Henry A. Waxman, as Amicus Curiae in Support of Petitioners, in Riegel v. Medtronic, Inc., 552 U.S. 312 (2008). (May 2008).
• Brief of Michael Green and Sander Greenland as Amici Curiae in Support of Plaintiffs-Appellants, in Rider v. Sandoz Pharmaceuticals, Inc., 295 F.3d 1194 (11th Cir. 2002). (May 2002).
• Comparative Fault and Damages in Relational Interest Tort Litigation, Iowa CLE (November 1986).

• Robert B. McKay Award for Advancement of Justice, Scholarship and the Legal Profession and for Outstanding Contributions to the Field of Tort (2018).
• William L. Prosser Award for Torts Scholarship and Teaching (2015).
• John G. Fleming Memorial Prize for Torts Scholarship (jointly with Bill Powers) (2012).
• R. Ammi Cutter Reporter (jointly with Bill Powers), American Law Institute (2001-05).

• Curriculum Vitae